Prediction Case File
YouTubeEvaluation Complete

The CHEAPEST Quality Stock In The Stock Market!

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
22 Jul 2026, 18:39 UTC
Recorded by Tahlil Plus
22 Jul 2026, 19:09 UTC
Video preview for The CHEAPEST Quality Stock In The Stock Market!
Source overview

AI-generated source summary

Uber's revenue growth has decelerated, with the latest quarter showing a 10% constant currency growth year-over-year, a significant drop from previous quarters. The company's non-GAAP earnings per share also show a slowdown. The acquisition of Delivery Hero, while expanding Uber's market reach, was seen as potentially overvalued. Uber is trading at approximately 12 times its projected free cash flow for the next year, which is considered cheap. The stock has been experiencing downward pressure, with the price dropping significantly over the past year. The speaker is selling put options and collecting premium, finding the stock to be undervalued and expecting it to remain below $60 in the short to medium term.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Source processing completed

    Source analysis and structured extraction completed.

  6. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  7. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail